Literature DB >> 22689727

Risperidone induced weight gain leading to benign intracranial hypertension.

Hira Ahmed1, Hala Ali.   

Abstract

Benign intracranial hypertension (BIH) is a condition which is strongly associated with weight gain. A well-known potential adverse effect of anti-psychotic treatment, especially the atypical group, is weight gain. Our case describes the use of risperidone in a young obese lady who gained significant weight after commencing the antipsychotic and later developed headache and blurred vision. Withdrawing the offending drug (causing reduction in her weight) in addition to acetazolamide drastically improved her symptoms within a month. Our case highlights that, obese patients started on antipsychotic medication, who develop headache, should be considered for investigation of BIH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22689727      PMCID: PMC3149430          DOI: 10.1136/bcr.06.2011.4320

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Risperidone-related weight gain: genetic and nongenetic predictors.

Authors:  Hsien-Yuan Lane; Yi-Ching Liu; Chieh-Liang Huang; Yue-Cune Chang; Po-Lun Wu; Chung-Ta Lu; Wen-Ho Chang
Journal:  J Clin Psychopharmacol       Date:  2006-04       Impact factor: 3.153

2.  Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

Authors:  Andrés Martin; Lawrence Scahill; George M Anderson; Michael Aman; L Eugene Arnold; James McCracken; Christopher J McDougle; Elaine Tierney; Shirley Chuang; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2004-06       Impact factor: 18.112

Review 3.  Management of antipsychotic-related weight gain.

Authors:  Lawrence Maayan; Christoph U Correll
Journal:  Expert Rev Neurother       Date:  2010-07       Impact factor: 4.618

Review 4.  Antipsychotic-induced weight gain: a comprehensive research synthesis.

Authors:  D B Allison; J L Mentore; M Heo; L P Chandler; J C Cappelleri; M C Infante; P J Weiden
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

5.  Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Authors:  J A Hellings; J R Zarcone; K Crandall; D Wallace; S R Schroeder
Journal:  J Child Adolesc Psychopharmacol       Date:  2001       Impact factor: 2.576

Review 6.  Diagnosis and management of benign intracranial hypertension.

Authors:  D Soler; T Cox; P Bullock; D M Calver; R O Robinson
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

7.  Effects of weight loss on the course of idiopathic intracranial hypertension in women.

Authors:  M J Kupersmith; L Gamell; R Turbin; V Peck; P Spiegel; M Wall
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

8.  Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri).

Authors:  Anthony B Daniels; Grant T Liu; Nicholas J Volpe; Steven L Galetta; Mark L Moster; Nancy J Newman; Valerie Biousse; Andrew G Lee; Michael Wall; Randy Kardon; Marie D Acierno; James J Corbett; Maureen G Maguire; Laura J Balcer
Journal:  Am J Ophthalmol       Date:  2007-04       Impact factor: 5.258

Review 9.  [Pseudotumor cerebri (PTC--an update)].

Authors:  Anat Kesler; Natan Gadoth
Journal:  Harefuah       Date:  2002-03

10.  A comparison of risperidone-induced weight gain across the age span.

Authors:  Daniel J Safer
Journal:  J Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.153

  10 in total
  3 in total

1.  Antipsychotic pitfalls: idiopathic intracranial hypertension and antipsychotic-induced weight gain.

Authors:  Hirofumi Namiki
Journal:  BMJ Case Rep       Date:  2020-06-30

2.  Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.

Authors:  Anil Kakunje; Ashwini Prabhu; Sindhu Priya Es; Ravichandra Karkal; Rahyanath K Pookoth; Rekha Pd
Journal:  J Clin Psychopharmacol       Date:  2018-12       Impact factor: 3.153

3.  Risperidone Induced Benign Intracranial Hypertension Leading to Visual Loss.

Authors:  Sushil Thomas Alexander; Dheeraj Kattula; Pavithra Mannam; Ramya Iyyadurai
Journal:  Indian J Psychol Med       Date:  2016 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.